The deal brings the FDA-approved neuroblastoma therapy Danyelza (naxitamab-gqgk) to SERB Pharmaceuticals and advances its ...

Primitive Neuroectodermal Tumors (PNET) Treatment Major Market Players The competitive landscape of the Primitive Neuroectodermal Tumors (PNET) treatment market includes major pharmaceutical players ...

ABSTRACT: Background: The primitive neuroectodermal tumor (PNET) belongs to the family of malignant small round cell tumors with neuroepithelial differentiation. Isolated cases of PNET have been ...

Primitive neuroectodermal tumors (PTNE), as in the case presented, are considered to be anatomically atypical tumor growth in animals and humans, making it difficult to determine the point of origin ...

A case of peripheral primitive neuroectodermal tumor in the cervical region of a canine is described. The patient was a canine, male, five years old, large size, with acute neurological clinical signs ...

ZFP207 modulates mouse ESCs pluripotency and neuroectodermal differentiation by integrating co‐ and post‐transcriptional mechanisms.

Malignant gastrointestinal neuroectodermal tumor (GNET) is an extremely rare soft tissue sarcoma, and has been designated as a new entity recently. At presen ...

Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. Peripheral primitive neuroectodermal tumors are small round cell neoplasms with neuroectodermal differentiation that ...

Keywords: ewing sarcoma, peripheral primitive neuroectodermal tumor, primary intracranial, diagnosis, central nervous system, treatment Citation: Jiang Y, Zhao L, Wang Y, Liu X, Wu X and Li Y (2020) ...

PURPOSE: To identify biologic prognostic factors in childhood primitive neuroectodermal tumors (PNET), including medulloblastoma, that accurately define patient groups with sufficiently good prognosis ...